Table 1.
Descriptive statistics of assessed patients with PSO, PSA with PSO, and PSA sine PSO.
| PSO | PSA with PSO | PSA sine PSO | |
|---|---|---|---|
| 19 | 41 | 20 | |
| Age, years, mean ± SD | 48.6 ± 15.8 | 54.7 ± 11.1 | 56.6 ± 12.9 |
| Male Sex, % | 47.4% | 29.3% | 15.0% |
| BMI, mean ± SD | 26.8 ± 5.2 | 27.4 ± 6.1 | 26.2 ± 3.5 |
| BMI≥ 30 | 36.8% | 34.1% | 35.0% |
| Dermatologic assessment | |||
| Plaque type PSO, % | 89.5% | 78.1% | 0.0% |
| Inverse genital PSO, % | 26.4% | 17.1% | 0.0% |
| Palmo plantar PSO, % | 26.3% | 24.4% | 0.0% |
| Guttate PSO, % | 36.8% | 34.1% | 0.0% |
| Psoriatic onychopathy, % | 52.6% | 70.7% | 0.0% |
| NAPSI, median (range) | 10.5 (50.0) | 19.0 (68.0) | 0.0 (0.0) |
| PASI, median (range) | 5.9 (18.3) | 2.5 (46.0) | 0.0 (0.0) |
| Rheumatologic assessment | |||
| Tender joints, median (range) | 0.0 (0.0) | 8.0 (46.0) | 8.0 (25.0) |
| Swollen joints, median (range) | 0.0 (0.0) | 1.0 (5.0) | 1.0 (4.0) |
| VAS pain, median (range) | 0.0 (5.0) | 5.5 (10.0) | 5.0 (8.0) |
| LEI, median (range) | 0.0 (0.0) | 2 (4.0) | 2 (3.0) |
PSO, psoriasis; PSA, psoriatic arthritis; BMI, body mass index; PASI, Psoriasis Area and Severity Index; NAPSI, Nail Area and Severity Index; VAS, visual analogue scale; LEI, Leed Enthesitis Index.